Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank67
3Y CAGR+32.1%
5Y CAGR+139.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+32.1%/yr
vs -28.2%/yr prior
5Y CAGR
+139.6%/yr
Recent deceleration
Acceleration
+60.3pp
Accelerating
Percentile
P67
Within normal range
vs 5Y Ago
78.9x
Strong expansion
Streak
5 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $3.60M | +8.9% |
| 2023 | $3.31M | +23.8% |
| 2022 | $2.67M | +71.0% |
| 2021 | $1.56M | +540.1% |
| 2020 | $244155.00 | +434.8% |
| 2019 | $45650.00 | -99.4% |
| 2018 | $8.26M | +40.1% |
| 2017 | $5.89M | -28.6% |
| 2016 | $8.26M | +444.4% |
| 2015 | $1.52M | - |